Bridgewater Advisors Inc. Bristol Myers Squibb CO Transaction History

Bridgewater Advisors Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$65.71 - $74.53 $12,024 - $13,638	-183 Reduced 1.76%	10,204 $707,000
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $398,279 - $471,619	-5,816 Reduced 35.89%	10,387 $0
Q3 2022 Oct 28, 2022	BUY	$0.13 - $76.84 $777 - $459,810	5,984 Added 58.56%	16,203 $1.15 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $317,567 - $349,752	-4,373 Reduced 29.97%	10,219 $787,000
Q1 2022 May 05, 2022	BUY	$61.48 - $73.72 $14,140 - $16,955	230 Added 1.6%	14,592 $1.07 Million
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $8,366 - $9,753	156 Added 1.1%	14,362 $895,000
Q3 2021 Nov 02, 2021	SELL	$59.17 - $69.31 $1.11 Million - $1.3 Million	-18,769 Reduced 56.92%	14,206 $841,000
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $667,699 - $727,124	10,785 Added 48.6%	32,975 $2.2 Million
Q1 2021 May 20, 2021	BUY	$59.34 - $66.74 $1.32 Million - $1.48 Million	22,190 New	22,190 $1.43 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bridgewater Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Bridgewater Advisors Inc. with notifications on news.